UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

6 hedge funds and large institutions have $1.45M invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
3
Calls
$289K
Puts
Net Calls
+$289K
Net Calls Change
+$57K
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
1
Jane Street
New York
$553K -$198K -7,641 -26%
TRCT
2
Tower Research Capital (TRC)
New York
$407K +$343K +13,275 +540%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$391K +$391K +15,074 New
UBS Group
4
UBS Group
Switzerland
$57K +$57K +2,190 New
Morgan Stanley
5
Morgan Stanley
New York
$21K
LTFS
6
Ladenburg Thalmann Financial Services
Florida
$19K
VF
7
Virtu Financial
New York
-$244K -8,328 Closed
EWA
8
Exencial Wealth Advisors
Oklahoma
-$209K -7,125 Closed
Simplex Trading
9
Simplex Trading
Illinois
-$9K -315 Closed